Marpai announced that it received notice from the Nasdaq Hearings Panel of The Nasdaq Stock Market that it has granted the company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market. Subject to the company meeting certain requirements by March 31, 2024, the Hearings Panel granted the company an extension until May 28, 2024, to regain compliance with the Market Value of Listed Securities requirement of $35,000,000 or satisfy any of the alternative requirements in Listing Rule 5550(b).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MRAI:
- 5 Stocks Corporate Insiders are Buying in March 2024
- MARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023
- Marpai announces agreement with regional organization based in the southeast
- Marpai Announces Major Financial Agreements for 2024
- Marpai Adjusts AXA Deal Terms, Sells Future Receipts
